Jundishapur J Chronic Dis Care

Image Credit:Jundishapur J Chronic Dis Care

Prevalence and Causes Related to Neonatal Mortality in Hospitalized Infants in Ahvaz, Iran: During the COVID-19

Author(s):
Maryam RostamiMaryam Rostami1, Alireza RahimifarAlireza Rahimifar2, Mehdi TorabizadehMehdi TorabizadehMehdi Torabizadeh ORCID3, Farkhondeh JamshidiFarkhondeh Jamshidi4,*
1Department of Social Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Golestan Hospital Clinical Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4Department of Forensic Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Jundishapur Journal of Chronic Disease Care:Vol. 14, issue 4; e164161
Published online:Aug 30, 2025
Article type:Research Article
Received:Jul 01, 2025
Accepted:Aug 14, 2025
How to Cite:Rostami M, Rahimifar A, Torabizadeh M, Jamshidi F. Prevalence and Causes Related to Neonatal Mortality in Hospitalized Infants in Ahvaz, Iran: During the COVID-19.Jundishapur J Chronic Dis Care.2025;14(4):e164161.https://doi.org/10.5812/jjcdc-164161.

Abstract

Background:

Despite global efforts to improve neonatal outcomes, many newborns still face severe health challenges within the first 28 days of life. Among approximately 130 million births annually, over 4 million neonatal deaths occur, primarily in developing countries like Iran.

Methods:

This retrospective hospital-based cohort study was conducted on all 441 infants admitted to the neonatal intensive care unit (NICU), pediatric ward, and emergency department at Abuzar Hospital of Ahvaz in 2020 - 2021 who died. Quantitative variables were summarized using means and standard deviations, and qualitative data using frequencies. Chi-square and one-way ANOVA tests were used to examine associations between variables and causes of death. A significance level of P < 0.05 was applied.

Results:

During this study, 441 neonatal deaths were recorded among the hospitalized children in Abuzar Hospital. The rate of mortality was higher in hospitalized boys than in girls (P < 0.050). The rate of mortality among hospitalized children was higher in natural births than in cesarean sections (P < 0.050). The most common causes of death in hospitalized children under 5 years were asphyxia at birth (38 cases), structural brain disorders (22 cases), structural cardiovascular anomalies (66 cases), structural gastrointestinal disorders (59 cases), congenital metabolic diseases (28 cases), respiratory failure (153 cases), and sepsis (75 cases). Infants with congenital heart anomalies died significantly earlier than others. No statistically significant associations were found between mortality causes and variables such as gender, parental consanguinity, maternal comorbidities, delivery type, blood group, and maternal age. However, NICU admission and prematurity were significantly associated with higher mortality across all causes (P < 0.001).

Conclusions:

Neonatal mortality remains high, with respiratory failure being the leading cause. This highlights the need for improved care strategies for high-risk neonates, particularly those with respiratory complications.

1. Background

Despite notable advancements in neonatal healthcare, many newborns worldwide continue to face serious health challenges during the first 28 days of life (1). The infant mortality rate is one of the important health indices in communities (2). In 2019, an estimated 2.4 million neonatal deaths occurred globally, equivalent to approximately 6,700 deaths per day, most of which happened within the first seven days after birth (1, 3). The most common causes of neonatal mortality include sepsis, birth-related trauma, and prematurity, which together account for nearly 75% of all neonatal deaths (4). Understanding the prevalence and associated factors of neonatal mortality is essential for implementing targeted interventions.

COVID-19 is a pandemic that has affected almost all countries, starting in 2019 in Wuhan, China (5, 6). Coronavirus disease has spread around the world and can not only be considered a health problem but also affects the global economy and the environment in various ways (7, 8). Pregnant women and their fetuses are considered high-risk populations during the COVID-19 outbreak. Pregnant women are more vulnerable during pregnancy and are at risk of contracting the disease due to their weakened immune systems and exposure to the general community (9, 10).

Globally, of the approximately 130 million infants born each year, more than 4 million die during the neonatal period, with 99% of these deaths occurring in low- and middle-income countries (11, 12). Over the past three decades, the decline in neonatal mortality has been significantly slower compared to the reductions observed in under-five and post-neonatal child mortality rates (13, 14).

According to the Convention on the Rights of the Child, every newborn has the fundamental right to attain the highest standard of health (15). However, recent reviews on child mortality have indicated a rising proportion of neonatal deaths during the first month of life relative to deaths among children under five years of age (16). Although approximately 40% of under-five deaths occur within the neonatal period, neonatal mortality was not originally included as a distinct target within the millennium development goals (MDGs) (17). Nevertheless, achieving the MDG target of reducing child mortality by two-thirds requires explicit attention to neonatal deaths.

The most important causes of infant mortality include premature birth and low birth weight, congenital anomalies, asphyxia or suffocation and trauma (impact), neonatal tetanus, diarrheal diseases, sudden infant death syndrome (SIDS), and neonatal infections such as sepsis (2, 18). To adopt a targeted, evidence-based approach to reduce neonatal mortality in Iran, a clear understanding of its magnitude and contributing factors is essential.

2. Objectives

This study aims to identify the determinants of neonatal mortality among all singleton neonates admitted to Abuzar Hospital in Ahvaz during the COVID-19 pandemic in the years 2020 and 2021 (1399 - 1400 in the Iranian calendar), using institutional data from Ahvaz Jundishapur University of Medical Sciences.

3. Methods

3.1. Study Setting and Population

This retrospective hospital-based cohort study was conducted to examine the records of neonatal deaths registered over a two-year period (2020 - 2021) in the neonatal intensive care unit (NICU) of Abuzar Hospital, affiliated with Ahvaz Jundishapur University of Medical Sciences, during the COVID-19 pandemic.

3.2. Inclusion and Exclusion Criteria

All neonatal deaths occurring within the first 28 days of life and recorded at Abuzar Hospital during the study period were included. Exclusion criteria were: Incomplete or conflicting medical records, births before 25 weeks of gestation, stillbirths (intrauterine deaths), and deaths occurring after 28 days of life.

3.3. Sampling Environment and Data Collection

Data and sampling environment were gathered from medical records across the NICU, pediatric ward, and emergency department of Abuzar Hospital. Information included neonatal admission date, age, birth weight, delivery status, diagnosis, treatments, cause of death, and comorbidities. Maternal data such as gestational age, maternal conditions, and mode of delivery were also recorded. All data were compiled using Microsoft Excel by one researcher and cross-validated for completeness and accuracy by a second researcher.

3.4. Data Analysis

Data were analyzed using SPSS version 20. Quantitative variables were reported as means and standard deviations, and categorical variables as frequencies and percentages. The chi-square test was used to assess associations between qualitative variables, while one-way ANOVA was applied for quantitative variables. A P-value of less than 0.05 was considered statistically significant.

3.5. Ethical Considerations

This study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences under the code IR.AJUMS.REC.1401.433. Additionally, the confidentiality of patient data and the anonymity of personal identifiers were fully ensured and maintained throughout the research process.

4. Results

A total of 441 neonatal deaths were recorded during the years 2020 and 2021, with 224 cases in 2020 and 217 in 2021. Of the deceased neonates, 238 were male and 203 were female. Vaginal delivery accounted for 235 cases, while 206 were born via cesarean section. In terms of gestational age, 186 neonates were preterm, 250 were term, and 5 were post-term.

The blood group distribution included 70 cases with group A, 78 with group B, 25 with group AB, and the rest with group O. Among the 441 deceased, 48 had Rh-negative blood, while the remainder were Rh-positive. Parental consanguinity was present in 222 cases, while 219 were non-consanguineous.

Among the 441 deceased neonates, 150 had documented prenatal complications, including 19 with clinical jaundice, 3 with COVID-19, 12 with respiratory distress, 10 with gastrointestinal anomalies requiring surgery (esophageal atresia, imperforate anus), and 106 who required NICU admission at birth due to low Apgar scores, resuscitation, suspected infections, or prematurity.

The causes of death were as follows: Thirty-eight cases due to birth asphyxia, 22 from structural brain abnormalities, 66 from congenital cardiovascular anomalies, 59 from gastrointestinal anomalies, 28 from inherited metabolic disorders, 153 from respiratory failure, and 75 from sepsis. A total of 82 mothers had recorded pregnancy-related conditions, including 37 with gestational diabetes, 20 with pregnancy-induced hypertension, 15 with preeclampsia, and 10 with hypothyroidism.

Table 1 presents the basic characteristics of the deceased neonates. Gestational age ranged from 25 to 41 weeks, with a mean of 34.40 ± 4.15 weeks. Birth weight ranged from 500 to 4600 g, with a mean of 2346.35 ± 872.87 g. Neonatal height ranged from 30 to 65 cm, with a mean of 45.44 ± 5.73 cm, and head circumference ranged from 21 cm, with a mean of 32 ± 4.43 cm.

Table 1.Baseline Characteristics of Deceased Neonates
VariablesMinimum-MaximumMean ± Standard Deviation
Gestational age at birth (wk)25.00 - 41.0034.39 ± 4.15
Birth weight (g)500 - 46002346.36 ± 872.87
Birth length (cm)30.00 - 65.0045.44 ± 5.73
Head circumference (cm)21.00 - 45.0032.00 ± 4.43
Maternal age (y)23.00 - 44.0028.96 ± 6.90
Age at NICU admission (d)0.00 - 28.004.55 ± 7.21
Length of hospital stay until death (d)0.00 - 28.004.67 ± 5.97

Age at NICU admission ranged from birth to 28 days, with a mean of 4.55 ± 7.21 days, and the duration of hospitalization until death ranged from 0 to 28 days, with a mean of 4.67 ± 5.97 days. Maternal age ranged from 23 to 45 years, with a mean age of 32.00 ± 4.43 years.

The detailed statistical findings are presented in Table 2. All causes of mortality were significantly more prevalent among neonates who required NICU admission at birth compared to those who did not, and among preterm neonates compared to term and post-term neonates (P < 0.001). Based on the results, there was a significant relationship between gestational age at birth (including asphyxia, brain structural abnormalities, cardiovascular anomalies, GI structural anomalies, metabolic disorders, respiratory failure, sepsis) and causes of neonatal death, with a mean gestational age of 35.39 ± 3.48 days (P < 0.050).

Table 2.Relationship Between Quantitative Variables and Causes of Neonatal Death
Variables; Cause of DeathMean ± Standard DeviationP-Value
Gestational age at birth (wk)< 0.001
Asphyxia35.12 ± 4.45
Brain structural abnormalities36.5 ± 2.68
Cardiovascular anomalies36.84 ± 3.46
GI structural anomalies36.0 ± 2.73
Metabolic disorders35.39 ± 3.55
Respiratory failure32.15 ± 4.04
Sepsis35.76 ± 3.49
Parity0.89
Asphyxia2.59 ± 1.53
Brain structural abnormalities2.73 ± 2.53
Cardiovascular anomalies2.36 ± 0.96
GI structural anomalies2.35 ± 1.59
Metabolic disorders2.06 ± 1.0
Respiratory failure2.38 ± 1.23
Sepsis2.43 ± 1.49
Apgar score0.007
Asphyxia5.0 ± 2.43
Brain structural abnormalities7.5 ± 1.58
Cardiovascular anomalies7.33 ± 2.69
GI structural anomalies6.57 ± 1.88
Metabolic disorders4.88 ± 3.14
Respiratory failure6.5 ± 2.33
Sepsis7.11 ± 2.28
Birth weight (g)< 0.001
Asphyxia2476.61 ± 810.57
Brain structural abnormalities2727.81 ± 747.5
Cardiovascular anomalies2950.58 ± 734.62
GI structural anomalies2600.32 ± 722.87
Metabolic disorders2298.89 ± 708.68
Respiratory failure1903.35 ± 832.33
Sepsis2528.3 ± 815.91
Birth length (cm)< 0.001
Asphyxia46.69 ± 4.57
Brain structural abnormalities45.85 ± 7.72
Cardiovascular anomalies46.85 ± 5.37
GI structural anomalies46.85 ± 4.33
Metabolic disorders47.63 ± 5.9
Respiratory failure43.25 ± 5.7
Sepsis46.92 ± 5.58
Head circumference (cm)< 0.001
Asphyxia32.18 ± 3.7
Brain structural abnormalities34.44 ± 3.36
Cardiovascular anomalies34.13 ± 2.3
GI structural anomalies34.05 ± 4.06
Metabolic disorders32.57 ± 5.09
Respiratory failure30.12 ± 4.75
Sepsis33.03 ± 3.43
Maternal age (y)0.59
Asphyxia29.68 ± 7.24
Brain structural abnormalities30.0 ± 6.14
Cardiovascular anomalies27.67 ± 5.49
GI structural anomalies30.59 ± 7.21
Metabolic disorders30.13 ± 7.16
Respiratory failure28.9 ± 7.36
Sepsis27.88 ± 6.59
Age at admission (d)< 0.001
Asphyxia2.61 ± 5.26
Brain structural abnormalities5.27 ± 7.34
Cardiovascular anomalies5.45 ± 7.82
GI structural anomalies2.88 ± 4.69
Metabolic disorders6.79 ± 7.95
Respiratory failure2.47 ± 5.78
Sepsis9.24 ± 8.93
Length of stay until death (d)< 0.001
Asphyxia3.26 ± 3.52
Brain structural abnormalities7.09 ± 7.26
Cardiovascular anomalies3.21 ± 4.51
GI structural anomalies7.1 ± 7.95
Metabolic disorders3.57 ± 5.06
Respiratory failure4.72 ± 5.96
Sepsis4.35 ± 5.61

The results of this study showed that birth weight and birth length were significantly correlated with causes of neonatal death, with means of 2497.98 ± 767.49 g and 46.29 ± 5.59 cm, respectively (P < 0.050). According to the chi-square test, there were no statistically significant associations between the cause of neonatal death and the following variables: Infant sex, parental consanguinity, maternal comorbidities during pregnancy, blood group, Rh factor, mode of delivery, parity, maternal age, or year of birth (P > 0.05).

However, based on one-way ANOVA analysis, respiratory failure as a cause of death was significantly associated with lower gestational age, lower Apgar scores, lower birth weight, shorter birth length, smaller head circumference, and younger age at admission. Additionally, neonates with congenital cardiovascular anomalies died significantly earlier than those with other causes.

5. Discussion

In the present study, the frequency and causes of neonatal deaths among singleton births at Abuzar Hospital of Ahvaz, Iran, were investigated during the COVID-19 pandemic in 2020 - 2021. During these years, 224 cases in 2020 and 217 in 2021 were recorded, totaling 441 neonatal deaths. The COVID-19 pandemic has significantly disrupted global healthcare systems, with profound consequences for maternal and neonatal outcomes. During the pandemic, emerging evidence from tertiary care centers, including those in low- and middle-income countries, indicates a noticeable shift in both the prevalence and causes of neonatal mortality among hospitalized infants.

In the present study, 238 neonates were male and 203 were female. The results showed that vaginal delivery accounted for 235 cases, while 206 were born via cesarean section. In Ghaem Hospital, Boskabadi et al. studied the causes and predisposing factors in neonatal mortality (19). The results of their study showed that of 1630 hospitalized neonates in this center, 162 (9.94%) died, and 63% of them weighed less than 1500 g (19). Mehrkas et al. in 2020 studied the causes of deaths and mortality rates among hospitalized children in Isfahan, Iran (20). They reported that the rate of mortality was higher in hospitalized boys than in girls (P < 0.050) (20). Also, in their study, the rate of mortality among hospitalized children was higher in natural births than in cesarean sections (P < 0.050) (20). The findings of the present study are similar to the aforementioned study.

In a similar study in northeastern India by Kataki et al., over a two-year period, the overall hospital death rate was higher in boys. The results of the present study regarding the causes of hospital mortality in hospitalized children are similar to previous studies (21).

According to the results, the number of neonates in terms of gestational age recorded as preterm, term, and post-term were 186, 250, and 5, respectively. Regarding Apgar scores at birth: One neonate had a score of 0, 7 had a score of 1, 7 had a score of 2, and 15 had a score of 3 — all of whom required resuscitation at birth. Additionally, 13 neonates had a score of 4, 12 scored 5, 55 scored 6, 50 scored 7, and the remaining had scores of 8 or higher.

A total of 82 mothers had recorded pregnancy-related conditions, including 37 with gestational diabetes, 20 with pregnancy-induced hypertension, 15 with preeclampsia, and 10 with hypothyroidism. Among the 441 deceased neonates, 150 had documented prenatal complications, including 19 with clinical jaundice, 3 with COVID-19, 12 with respiratory distress, 10 with gastrointestinal anomalies requiring surgery (e.g., esophageal atresia, imperforate anus), and 106 who required NICU admission at birth due to low Apgar scores, resuscitation, suspected infections, or prematurity.

The blood group distribution included 70 cases with group A, 78 with group B, 25 with group AB, and the rest with group O. Among the 441 deceased, 48 had Rh-negative blood, while the remainder were Rh-positive. Parental consanguinity was present in 222 cases, while 219 were non-consanguineous.

The causes of death were as follows: Thirty-eight cases due to birth asphyxia, 22 from structural brain abnormalities, 66 from congenital cardiovascular anomalies, 59 from gastrointestinal anomalies, 28 from inherited metabolic disorders, 153 from respiratory failure, and 75 from sepsis.

Based on the study reported by Boskabadi et al., the major causes of neonatal mortality were severe prematurity (less than 32 weeks) at 57.4%, asphyxia (5-minute Apgar less than 6) at 30.86%, congenital anomalies at 27.16%, infections at 25.3%, respiratory complications at 24.7%, hematologic disorders at 6.8%, and cerebral disorders at 6.2% (19). The results of this study were similar to those of the Boskabadi et al. study 19.

In Hamadan province, the rate and causes of neonatal mortality were investigated by Oshvandi et al. (22). Based on their study, the most frequent causes of neonatal death were respiratory distress syndrome at 55.5%, sepsis at 10.2%, asphyxia at 8.7%, congenital anomalies at 6.6%, and DIC at 5.7%. The least frequent causes were hypoglycemia at 0.3% and convalescence at 0.9%. They found a relationship between birth weight (P = 0.002), gestational age (P = 0.001), infant age (P < 0.001), maternal age at delivery (P < 0.001), and congenital abnormality (P < 0.001) with the cause of death (22), which is similar to the results of our study.

Mehrkash et al. reported that the most common cause of hospital deaths in children was infections, followed by heart disease (20), which shows that the results of the present study are also consistent. The most common global causes of neonatal mortality include complications related to preterm birth (such as respiratory failure), birth trauma (asphyxia), infectious diseases (e.g., pneumonia, tetanus, diarrhea, sepsis), and congenital and metabolic disorders. Similarly, in the current study, respiratory failure due to prematurity was the leading cause of death, accounting for 153 cases (34.69%).

In countries like Iran, where regional hospitals such as Abuzar Hospital in Ahvaz serve as referral centers for critical neonatal cases, the burden was particularly acute. The pandemic led to increased delays in maternal referrals, reduced access to timely obstetric and neonatal care, and resource constraints in NICUs. Globally, approximately 2.8 million neonates die each year, with 73% of these deaths occurring during the first week of life (11). In line with global data, the present study found that the mean age at NICU admission was 4.55 ± 7.21 days, and the mean duration of hospitalization until death was 4.67 ± 5.97 days (11). These findings are consistent with reports from WHO and UNICEF, which highlight the vulnerability of neonatal care systems during global emergencies.

Congenital anomalies are another major cause of neonatal death, accounting for 5% to 38% of total neonatal deaths worldwide (23). In high-income countries, the proportion of deaths due to congenital anomalies is higher than in low-income settings, primarily because advanced antenatal care has successfully reduced other preventable causes of neonatal mortality (24, 25). For example, in low-income countries, birth asphyxia accounts for approximately 25% of neonatal deaths, and 98% of all global asphyxia-related deaths occur in these countries (26, 27). In our study, 147 cases (33.3%) were due to congenital anomalies — including cardiovascular, neurological, and gastrointestinal defects — while 8.62% were attributed to asphyxia. These findings suggest that Iran's neonatal mortality profile resembles that of high-income countries.

Neonatal infections, including sepsis, also represent a substantial portion of deaths in low- and middle-income countries — around 27% — whereas in high-income nations, they account for only 3.4% of neonatal deaths (28, 29). In the present study, sepsis was responsible for 75 deaths (17%), aligning Iran more closely with developing countries in this regard. Notably, the potential impact of COVID-19 on neonatal mortality cannot be ignored, as several deaths were associated with neonatal COVID-19 infection. The results of this study showed that respiratory failure was more common in neonates with lower gestational age, birth weight, Apgar score, height, and head circumference at admission.

Overall, my results likely reflect a confluence of pandemic-associated factors, including maternal COVID-19, healthcare strain, and established neonatal vulnerabilities. Comparisons with national registry data and similar regional studies underscore persistent themes but also highlight a potential elevation in mortality at medical centers like Abuzar Hospital during the pandemic.

5.1. Conclusions

Neonatal mortality remains a significant public health concern, with respiratory failure identified as the most common cause of death among newborns. Considering the high prevalence of premature death in infants less than 37 weeks of gestation, more attention should be paid to the control of preterm delivery in order to prevent respiratory distress syndrome and birth asphyxia. This condition is especially prevalent in high-risk neonates, highlighting the urgent need for targeted preventive measures, strengthening NICU infrastructure and staffing, ensuring uninterrupted access to essential neonatal medications and equipment, integrating maternal-neonatal care with infectious disease preparedness, and improving clinical interventions to reduce mortality rates associated with neonatal respiratory complications.

5.2. Strengths

The COVID-19 pandemic revealed critical vulnerabilities in maternal and neonatal healthcare delivery, particularly in low-resource and high-demand settings. Addressing these challenges through policy, infrastructure, and clinical innovation will be essential to improving neonatal survival in both routine and crisis settings.

5.3. Limitations

It is important to acknowledge that this study was conducted in a single hospital in Ahvaz, which limits the generalizability of the findings to the national level. Furthermore, the data pertain to the COVID-19 pandemic period, during which many mothers may have avoided hospital visits due to fear of infection. This may have influenced the overall mortality profile and must be considered when interpreting the results. Hence, further multicenter studies across the country are strongly recommended to validate and expand upon these findings.

5.4. Confounding Factors

Many confounding factors can affect infant mortality. These include maternal factors, infant factors, and environmental factors. Some maternal risk factors include the young age of the mother, smoking during pregnancy, inadequate care during pregnancy, not breastfeeding the baby, and alcohol or drug use. Infant-related factors include low birth weight and premature birth, as babies born before their due date often have more health problems and are at higher risk of death. Some babies are born with birth defects that can lead to their death, and respiratory and other infections can also increase the risk of infant mortality. In addition, environmental factors can be dangerous, such as babies sleeping on their stomachs, sleeping on soft surfaces (such as pillows or sharing a bed), and overheating, which can lead to SIDS. Finally, poverty, lack of access to health and education services, and other social problems can affect infant mortality.

Footnotes

References

  • 1.
    Lehtonen L, Gimeno A, Parra-Llorca A, Vento M. Early neonatal death: A challenge worldwide. Semin Fetal Neonatal Med. 2017;22(3):153-60. [PubMed ID: 28238633]. https://doi.org/10.1016/j.siny.2017.02.006.
  • 2.
    Basiri B, Shokoohi M, Otogara M, Shirmohamadi N, Shayan A. [Evaluation of the Frequency and Causes of Infants Mortality in the Neonatal Intensive Care Unit at Fatemieh Hospital of Hamadan, Iran, 2015]. Iran J Rehabil Res Nurs. 2018;4(3):25-30. FA.
  • 3.
    Tessema GA, Berheto TM, Pereira G, Misganaw A, Kinfu Y, G. B. D. Ethiopia Child Mortality Collaborators. National and subnational burden of under-5, infant, and neonatal mortality in Ethiopia, 1990-2019: Findings from the Global Burden of Disease Study 2019. PLOS Glob Public Health. 2023;3(6). e0001471. [PubMed ID: 37343009]. [PubMed Central ID: PMC10284418]. https://doi.org/10.1371/journal.pgph.0001471.
  • 4.
    Rosa-Mangeret F, Benski AC, Golaz A, Zala PZ, Kyokan M, Wagner N, et al. 2.5 Million Annual Deaths-Are Neonates in Low- and Middle-Income Countries Too Small to Be Seen? A Bottom-Up Overview on Neonatal Morbi-Mortality. Trop Med Infect Dis. 2022;7(5). [PubMed ID: 35622691]. [PubMed Central ID: PMC9148074]. https://doi.org/10.3390/tropicalmed7050064.
  • 5.
    Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9. [PubMed ID: 32015508]. [PubMed Central ID: PMC7094943]. https://doi.org/10.1038/s41586-020-2008-3.
  • 6.
    Poursaleh S, Dehghan Nayeri N, Khatami F, Bakhshi A, Ebadati Nakhjiri N, Shafiee Sabet M. Investigating the Effect of COVID-19 Vaccination on the Course of Disease and Recurrence of Attacks in Patients with Multiple Sclerosis. Jundishapur J Chronic Dis Care. 2024;14(1). https://doi.org/10.5812/jjcdc-154203.
  • 7.
    Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. [PubMed ID: 32015507]. [PubMed Central ID: PMC7095418]. https://doi.org/10.1038/s41586-020-2012-7.
  • 8.
    Nikmanesh Y, Zarea K, Hatamzadeh N, Cheraghi M, Taherian M, Jalali S, et al. Effect of COVID-19 and Air Pollution on the Risk Factors Attributed to COPD, Cardiovascular, and Respiratory Diseases. Jundishapur J Chronic Dis Care. 2023;13(1). https://doi.org/10.5812/jjcdc-139881.
  • 9.
    Mirzakhani K, Shoorab NJ, Akbari A, Khadivzadeh T. High-risk pregnant women's experiences of the receiving prenatal care in COVID-19 pandemic: a qualitative study. BMC Pregnancy Childbirth. 2022;22(1):363. [PubMed ID: 35473593]. [PubMed Central ID: PMC9040690]. https://doi.org/10.1186/s12884-022-04676-1.
  • 10.
    Barzegar M, Salmei S, kamiab Z. [Neonatal and Maternal Outcomes Before and After COVID-19 Pandemic: A Cross-Sectional Study]. J Rafsanjan Univ Med Sci. 2024;23(2):157-68. FA. https://doi.org/10.61186/jrums.23.2.157.
  • 11.
    Saha U. Neonatal Mortality and Morbidity: The Burden. In: Saha U, editor. Clinical Anesthesia for the Newborn and the Neonate. New York, USA: Springer Nature Singapore; 2023. p. 3-10. https://doi.org/10.1007/978-981-19-5458-0_1.
  • 12.
    Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet. 2005;365(9462):891-900. [PubMed ID: 15752534]. https://doi.org/10.1016/S0140-6736(05)71048-5.
  • 13.
    Moss W, Darmstadt GL, Marsh DR, Black RE, Santosham M. Research priorities for the reduction of perinatal and neonatal morbidity and mortality in developing country communities. J Perinatol. 2002;22(6):484-95. [PubMed ID: 12168128]. https://doi.org/10.1038/sj.jp.7210743.
  • 14.
    Ogbo FA, Ezeh OK, Awosemo AO, Ifegwu IK, Tan L, Jessa E, et al. Determinants of trends in neonatal, post-neonatal, infant, child and under-five mortalities in Tanzania from 2004 to 2016. BMC Public Health. 2019;19(1):1243. [PubMed ID: 31500599]. [PubMed Central ID: PMC6734430]. https://doi.org/10.1186/s12889-019-7547-x.
  • 15.
    Saugstad OD, Stokkereit I. Children's Right to Health: Implications for Decision-Making in Newborn Medical Care. Pediatrics. 2016;138(1). [PubMed ID: 27260696]. https://doi.org/10.1542/peds.2015-4195.
  • 16.
    Hug L, Alexander M, You D, Alkema L; U. N. Inter-agency Group for Child Mortality Estimation. National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis. Lancet Glob Health. 2019;7(6):e710-20. [PubMed ID: 31097275]. [PubMed Central ID: PMC6527519]. https://doi.org/10.1016/S2214-109X(19)30163-9.
  • 17.
    Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2022;6(2):106-15. [PubMed ID: 34800370]. [PubMed Central ID: PMC8786667]. https://doi.org/10.1016/S2352-4642(21)00311-4.
  • 18.
    Wudu MA, Wondifraw EB, Getaneh FB, Hailu MK, Belete MA, Yosef ST, et al. Incidence and predictors of mortality among neonates admitted with birth asphyxia to neonatal intensive care units in Ethiopia: a systematic review and meta-analysis. BMC Pediatr. 2025;25(1):140. [PubMed ID: 40001015]. [PubMed Central ID: PMC11863858]. https://doi.org/10.1186/s12887-025-05481-3.
  • 19.
    Boskabadi H, Parvini Z, Barati T, Moudi A. [Study of the Causes and Predisposing Factors in Neonatal Mortality in Ghaem Hospital (March 2009 to May 2010)]. Iran J Obstet, Gynecol Infertility. 2012;14(7):6-14. FA. https://doi.org/10.22038/ijogi.2012.6004.
  • 20.
    Mehrkash M, Kermani R, Hossienifard R, Mostafizadeh N, Hovsepian S. [Hospital Mortality Rate and Causes of Deaths among the Hospitalized Children in Imam Hossein Children’s Hospital in Isfahan, Iran, during the Years 2012-2017]. J Isfahan Med Sch. 2020;37(556):1361-8. FA. https://doi.org/10.22122/jims.v37i556.12187.
  • 21.
    Kataki RP, Gogoi A, Bora CJ, Dowerah P, Baruah M. Mortality pattern of hospitalized children in a referral hospital from Upper Assam, North East India: A record based retrospective analysis. Congenital Heart Disease. 2016;1:0.6.
  • 22.
    Oshvandi K, Soori E, Zamanian L. [The rate and causes of neonatal mortality in Hamadan province, 2012]. Avicenna J Nurs Midwifery Care. 2016;24(4):281-300. FA. https://doi.org/10.21859/nmj-24049.
  • 23.
    Kang L, Cao G, Jing W, Liu J, Liu M. Global, regional, and national incidence and mortality of congenital birth defects from 1990 to 2019. Eur J Pediatr. 2023;182(4):1781-92. [PubMed ID: 36781460]. https://doi.org/10.1007/s00431-023-04865-w.
  • 24.
    Global PaedSurg Research C. Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study. Lancet. 2021;398(10297):325-39. [PubMed ID: 34270932]. [PubMed Central ID: PMC8314066]. https://doi.org/10.1016/S0140-6736(21)00767-4.
  • 25.
    Glinianaia SV, Morris JK, Best KE, Santoro M, Coi A, Armaroli A, et al. Long-term survival of children born with congenital anomalies: A systematic review and meta-analysis of population-based studies. PLoS Med. 2020;17(9). e1003356. [PubMed ID: 32986711]. [PubMed Central ID: PMC7521740]. https://doi.org/10.1371/journal.pmed.1003356.
  • 26.
    Moshiro R, Mdoe P, Perlman JM. A Global View of Neonatal Asphyxia and Resuscitation. Front Pediatr. 2019;7:489. [PubMed ID: 31850287]. [PubMed Central ID: PMC6902004]. https://doi.org/10.3389/fped.2019.00489.
  • 27.
    Shukla VV, Carlo WA, Niermeyer S, Guinsburg R. Neonatal resuscitation from a global perspective. Semin Perinatol. 2022;46(6):151630. [PubMed ID: 35725655]. https://doi.org/10.1016/j.semperi.2022.151630.
  • 28.
    Imam FB, Darmstadt GL, Zaidi AK. 2 - Neonatal infections: A global perspective. In: Maldonado YA, Nizet V, Barnett ED, Edwards KM, Malley R, Remington JS, et al., editors. Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant (Ninth Edition). Philadelphia, Pennsylvania: Elsevier; 2025. p. 21-53.e11. https://doi.org/10.1016/B978-0-323-79525-8.00011-1.
  • 29.
    Russell NJ, Stohr W, Plakkal N, Cook A, Berkley JA, Adhisivam B, et al. Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS). PLoS Med. 2023;20(6). e1004179. [PubMed ID: 37289666]. [PubMed Central ID: PMC10249878]. https://doi.org/10.1371/journal.pmed.1004179.
Indexed in

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles